CK Life Sciences Int'l., (Holdings) Inc. (0775.HK) HKSE

0.91

+0.02(+2.25%)

Updated at October 20 09:50AM

Currency In HKD

Valuation

Market Cap3.94B
Enterprise Value9.49B
P/E Ratio-30.73
PEG Ratio0.26
Price/Sales Ratio1.56
Price/Book Ratio2.34
Enterprise/Revenue2.6
Enterprise/EBITDA1,518.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.05
Operating Margin0.11

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.08

Income Statement

Revenue5.52B
Revenue/Share0.57
Gross Profit1.69B
EBITDA337.27M
Net Income-126.55M
Diluted EPS-0.01

Balance Sheet

Total Cash797.84M
Total Cash/Share0.08
Total Debt6.5B
Total Debt/Equity1.78
Current Ratio1.49
Book Value Per Share0.38

Price History

52-Week Change85.42
52-Week High1.1
52-Week Low0.4
Moving Average 50 Days0.95
Moving Average 200 Days0.75

Statistics

Average Volume8.91M
Shares Outstanding9.61B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A